Taking Added Advantage Of Reality: Johnson & Johnson, Pfizer, Qualcomm, Visa, Berkshire Hathaway |
February 25, 2013 | February 2013 Bond Updates |
Barry Ritholtz, CEO and Director of Equity Research, Fusion IQ |
View more at: http://www.forbes.com/sites/wallaceforbes/2013/02/22/taking-added-advantage-of-reality-johnson-johnson-pfizer-qualcomm-visa-berkshire-hathaway/ |
Related News |